WallStreetZenWallStreetZen

NASDAQ: GRAL
Grail Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for GRAL

Based on 1 analyst offering 12 month price targets for Grail Inc

Min Forecast
$20.00-25.93%
Avg Forecast
$20.00-25.93%
Max Forecast
$20.00-25.93%

Should I buy or sell GRAL stock?

Based on 1 analyst offering ratings for Grail Inc.

Hold
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
1 analysts 100%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Our proven Zen Rating quant model agrees with analyst consensus with a "Hold" rating. Learn More

Be the first to know when Wall Street analysts revise their GRAL stock forecasts and price targets.

GRAL stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-03-18

1 of 1

Forecast return on equity

Is GRAL forecast to generate an efficient return?

Company
-11.21%
Industry
-10.5%
Market
61.97%
GRAL's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is GRAL forecast to generate an efficient return on assets?

Company
-9.41%
Industry
12.56%
GRAL is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

GRAL earnings per share forecast

What is GRAL's earnings per share in the next 3 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$14.56
Avg 2 year Forecast
-$11.81
Avg 3 year Forecast
-$8.28

GRAL revenue forecast

What is GRAL's revenue in the next 3 years based on estimates from 1 analyst?

Avg 1 year Forecast
$149.4M+18.98%
Avg 2 year Forecast
$163.1M+29.83%
Avg 3 year Forecast
$171.8M+36.81%
GRAL's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

GRAL revenue growth forecast

How is GRAL forecast to perform vs Diagnostics & Research companies and vs the US market?

Company
13.37%
Industry
5.29%
Market
10.7%
GRAL's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
GRAL's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

GRAL vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
GRAL$27.00$20.00-25.93%Hold
NEOG$4.39$9.75+122.10%Buy
OPK$1.42$2.63+84.86%Buy
CDNA$17.62$30.00+70.26%Buy
MYGN$7.64$18.35+140.18%Buy
View Top Diagnostic & Research Stocks

Grail Stock Forecast FAQ

Is Grail Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: GRAL) stock is to Hold GRAL stock.

Out of 1 analyst, 0 (0%) are recommending GRAL as a Strong Buy, 0 (0%) are recommending GRAL as a Buy, 1 (100%) are recommending GRAL as a Hold, 0 (0%) are recommending GRAL as a Sell, and 0 (0%) are recommending GRAL as a Strong Sell.

If you're new to stock investing, here's how to buy Grail stock.

What is GRAL's earnings growth forecast for 2025-2027?

(NASDAQ: GRAL) Grail's forecast annual earnings growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of 29.98%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 23.64%.

Grail's earnings in 2025 is -$2,027,005,000.On average, 1 Wall Street analyst forecast GRAL's earnings for 2025 to be -$493,514,782, with the lowest GRAL earnings forecast at -$493,514,782, and the highest GRAL earnings forecast at -$493,514,782. On average, 1 Wall Street analyst forecast GRAL's earnings for 2026 to be -$400,302,855, with the lowest GRAL earnings forecast at -$400,302,855, and the highest GRAL earnings forecast at -$400,302,855.

In 2027, GRAL is forecast to generate -$280,652,637 in earnings, with the lowest earnings forecast at -$280,652,637 and the highest earnings forecast at -$280,652,637.

What is GRAL's revenue growth forecast for 2025-2027?

(NASDAQ: GRAL) Grail's forecast annual revenue growth rate of 13.37% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.29%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.7%.

Grail's revenue in 2025 is $125,595,000.On average, 1 Wall Street analysts forecast GRAL's revenue for 2025 to be $5,065,203,877, with the lowest GRAL revenue forecast at $5,065,203,877, and the highest GRAL revenue forecast at $5,065,203,877. On average, 1 Wall Street analysts forecast GRAL's revenue for 2026 to be $5,526,823,232, with the lowest GRAL revenue forecast at $5,526,823,232, and the highest GRAL revenue forecast at $5,526,823,232.

In 2027, GRAL is forecast to generate $5,823,948,958 in revenue, with the lowest revenue forecast at $5,823,948,958 and the highest revenue forecast at $5,823,948,958.

What is GRAL's forecast return on assets (ROA) for 2025-2027?

(NASDAQ: GRAL) forecast ROA is -9.41%, which is lower than the forecast US Diagnostics & Research industry average of 12.56%.

What is GRAL's Price Target?

According to 1 Wall Street analyst that have issued a 1 year GRAL price target, the average GRAL price target is $20.00, with the highest GRAL stock price forecast at $20.00 and the lowest GRAL stock price forecast at $20.00.

The Wall Street analyst predicted that Grail's share price could fall to $20.00 by Mar 18, 2026. The average Grail stock price prediction forecasts a potential downside of 25.93% from the current GRAL share price of $27.00.

What is GRAL's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: GRAL) Grail's current Earnings Per Share (EPS) is -$63.54. On average, analysts forecast that GRAL's EPS will be -$14.56 for 2025, with the lowest EPS forecast at -$14.56, and the highest EPS forecast at -$14.56. On average, analysts forecast that GRAL's EPS will be -$11.81 for 2026, with the lowest EPS forecast at -$11.81, and the highest EPS forecast at -$11.81. In 2027, GRAL's EPS is forecast to hit -$8.28 (min: -$8.28, max: -$8.28).

What is GRAL's forecast return on equity (ROE) for 2025-2027?

(NASDAQ: GRAL) forecast ROE is -11.21%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.